The Sofosbuvir (SOF) and Velpatasvir (VEL) Regimen is Associated with High Efficacy and Improvement of Patient-Reported Outcomes (PROs) in Patients Co-infected with Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV): The Data from ASTRAL-5

Younossi Zobair M.; Stepanova Maria; Sulkowski Mark S.; Wyles David L.; Kottilil Shyam; Hunt Sharon

首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >The Sofosbuvir (SOF) and Velpatasvir (VEL) Regimen is Associated with High Efficacy and Improvement of Patient-Reported Outcomes (PROs) in Patients Co-infected with Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV): The Data from ASTRAL-5

【24h】

The Sofosbuvir (SOF) and Velpatasvir (VEL) Regimen is Associated with High Efficacy and Improvement of Patient-Reported Outcomes (PROs) in Patients Co-infected with Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV): The Data from ASTRAL-5

机译：Sofosbuvir（SOF）和VelpataSvir（VelpataSvir（velpataSvir（velpatasvir（velpatasvir（velpatasvir）与患者报告的患者报告的患者的高效性和改善有关，患者患者与丙型肝炎病毒（HCV）和人类免疫缺陷病毒（HIV）（HIV）：来自星式的数据 -5

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2016年第s1期|共1页
作者
Younossi Zobair M.; Stepanova Maria; Sulkowski Mark S.; Wyles David L.; Kottilil Shyam; Hunt Sharon;
展开▼
作者单位

Inova Fairfax Hosp Dept Med Ctr Liver Dis Falls Church VA USA;

Ctr Outcomes Res Liver Dis Washington DC USA;

Johns Hopkins Univ Baltimore MD USA;

Univ Calif San Diego San Diego CA 92103 USA;

Univ Maryland Baltimore MD 21201 USA;

Ctr Outcomes Res Liver Dis Washington DC USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Multidisciplinary Approach to Drug-Drug Interactions between Tacrolimus and Sofosbuvir/Velpatasvir and Glecaprevir/Pibrentasvir in Kidney Transplant Patients during Hepatitis C Treatment:A Case Series Report [J] . Tung Huynh, Uttam Reddy, Ke-Qin Hu 药剂与药理学：英文版 . 2021,第006期
2. The Sofosbuvir (SOF) and Velpatasvir (VEL) Regimen is Associated with High Efficacy and Improvement of Patient-Reported Outcomes (PROs) in Patients Co-infected with Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV): The Data from ASTRAL-5 [J] . Younossi Zobair M., Stepanova Maria, Sulkowski Mark S., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：Sofosbuvir（SOF）和VelpataSvir（VelpataSvir（velpataSvir（velpatasvir（velpatasvir（velpatasvir）与患者报告的患者报告的患者的高效性和改善有关，患者患者与丙型肝炎病毒（HCV）和人类免疫缺陷病毒（HIV）（HIV）：来自星式的数据 -5
3. Sofosbuvir/Velpatasvir (SOF/VEL)-Based Regimens are Associated with Excellent Efficacy and a Significant Improvement of Patients-Reported Outcomes (PROs) across Patient Populations: From Non-Cirrhotics to Compensated Cirrhotics to Decompensated Cirrhotics [J] . Younossi Zobair M., Stepanova Maria, Feld Jordan J., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：基于Sofosbuvir / VelpataSvir（SOF / VEL）的方案与患者群体的患者报告的结果（专业人士）的优异疗效和显着改善有关：从非循环系统到补偿循环循环循环
4. Efficacy and safety of Sofosbuvir-containing regimens in patients co-infected with chronic hepatitis C virus and human immunodeficiency virus: a meta-analysis [J] . Guotao Li, Ke Zang, Guoqiang Zhang, Virology Journal . 2018,第1期

机译：含Sofosbuvir方案在慢性丙型肝炎病毒和人类免疫缺陷病毒共同感染患者中的疗效和安全性：一项荟萃分析
5. Simultaneous extraction of human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) RNA with the M1000 apparatus does not impair the measurement of the viral load of both viruses when tested by using the LCx PCR system [C] . T. Bourlet, S. Thamm, S. Pillet, European Congress of Virology . 2004

机译：通过使用LCX PCR系统测试，同时提取人免疫缺陷病毒类型1（HIV-1）和丙型肝炎病毒（HCV）RNA，不会损害两种病毒的病毒载量的测量
6. Hepatitis C virus (HCV) replication in vitro and the effect of HCV on human immunodeficiency virus (HIV-1) coreceptor usage and diversity in the coinfected patient. [D] . Franco, Kelly Flory. 2007

机译：丙型肝炎病毒（HCV）的体外复制以及HCV对合并感染患者中人免疫缺陷病毒（HIV-1）共受体使用和多样性的影响。
7. Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated WithHigh Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials [O] . Zobair M. Younossi, Maria Stepanova, Mark Sulkowski, -1

机译：索非布韦和维帕他韦的无利巴韦林治疗方案与基因型2的疗效高患者报告的结果有所改善和3种慢性丙型肝炎：来自Astral-2和-3临床试验的结果
8. Efficacy and safety of Sofosbuvir-containing regimens in patients co-infected with chronic hepatitis C virus and human immunodeficiency virus: a meta-analysis [O] . Guotao Li, Ke Zang, Guoqiang Zhang, 2018

机译：含有含有慢性丙型肝炎病毒和人免疫缺陷病毒的患者含Sofosbuvir的方案的疗效和安全性：Meta分析

The Sofosbuvir (SOF) and Velpatasvir (VEL) Regimen is Associated with High Efficacy and Improvement of Patient-Reported Outcomes (PROs) in Patients Co-infected with Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV): The Data from ASTRAL-5

著录项

相似文献

相关主题

期刊订阅